ProKidney Corp.
ProKidney Corp. (PROK) Revenue
Annual & quarterly revenue history · segment & region breakdown
PROK · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsProKidney Corp. trailing twelve-month (TTM) revenue is $0.00B, an increase of 1075.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | +$0.00B | +1075.00% |
| 2024-12-31 | $0.00B | +$0.00B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | — | — |
Compare revenue vs peers
BiotechnologyCompare PROK revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income ProKidney Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
ProKidney Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from ProKidney Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PROK revenue · 4 questionsPROK's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 1075.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · ProKidney Corp. SEC filings · GAAP · ProKidney Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026